Primary plasma cell leukemia (pPCL) is a rare and highly aggressive plasma cell malignancy, often associated with complex ...
Singapore, Singapore, October 7th, 2025, ChainwirePendle Finance, the world’s biggest yield trading platform in ...
Daily Voice Fairfax County, VA on MSN
‘Please Pray for Frankie’: Maryland Puppy Fights for Life After Devastating Crash
Frankie, a playful baby dachshund just a few months old, is fighting through unimaginable odds after being hit by a car and ...
MedPage Today on MSN
Myeloma Drug Performs Well in Autoimmune Diseases
Novel therapies for certain autoimmune diseases have been developed to end B cell-driven immune attacks on normal tissues.
Andhra Pradesh Health Minister addresses blood donation challenges, emphasizes rational blood use to prevent shortages and ...
While total outward FDI dipped year-on-year, equity commitments tripled to $2.57 billion; Prime Focus, Intas, and Zydus among ...
Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people living with rare diseases, and Protalix BioTherapeutics, Inc.
The FDA has approved Kedrion Biopharma’s Qivigy, a 10% IV immunoglobulin therapy, for treating adults who have primary ...
Discover JECT's latest medical-grade, innovative treatments to transform the skin, from Aquagold to wrinkle reducers.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback